Evidence map›Paper›PMID 32510949›Full record

ArticleJournal of natural products2020

Leucinostatins from

Yun-Seo Kil, April L Risinger, Cora L Petersen, Susan L Mooberry, Robert H Cichewicz

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of natural products, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Genomic comparative analysis ofFrontiers in microbiology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yun-Seo KilNatural Products Discovery Group, Institute for Natural Products Applications and Research Technologies, Department of Chemistry & Biochemistry, Stephenson Life Science Research Center, University of Oklahoma, 102 Stephenson Parkway, Norman, Oklahoma 73019, United States.
April L RisingerORCID 0000-0002-4363-3268
Cora L Petersen
Susan L MooberryORCID 0000-0001-8575-2516
Robert H CichewiczNatural Products Discovery Group, Institute for Natural Products Applications and Research Technologies, Department of Chemistry & Biochemistry, Stephenson Life Science Research Center, University of Oklahoma, 102 Stephenson Parkway, Norman, Oklahoma 73019, United States.ORCID 0000-0003-0744-4117
The University of Texas Health Science Center at San Antonio · USUniversity of Oklahoma · USThe University of Texas System · US

Funding

New Leads for Triple Negative Breast Cancer from Diverse Natural SourcesU01CA182740 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CICHEWICZ, ROBERT HENRY, MOOBERRY, SUSAN L · 2014 to 2018
$2.3M
NCI NIH HHS U01 CA182740
6 · The paper itself

Abstract

The structures of four leucinostatin analogues (

Indexed as

Antibiotics, AntineoplasticAntimicrobial Cationic PeptidesAscomycotaCell Line, TumorChromatography, High Pressure LiquidCordycepsDrug Screening Assays, AntitumorFemaleHumansHydrolysisMagnetic Resonance SpectroscopyMitochondriaOxygen ConsumptionReceptors, AndrogenSpectrometry, Mass, Electrospray IonizationTriple Negative Breast NeoplasmsAntibiotics, AntineoplasticAntimicrobial Cationic Peptidesleucinostatin Aleucinostatin BReceptors, Androgen

Identifiers

PMID32510949
PMCPMC7704123
OpenAlexW3033833142

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.